Find Research Outputs

Search concepts
Selected Filters
2020

A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive Dyskinesia

Caroff, S. N., Citrome, L., Meyer, J., Sajatovic, M., Goldberg, J. F., Jain, R., Lundt, L., Lindenmayer, J. P., McEvoy, J. P., McIntyre, R. S., Tohen, M. & Ketter, T. A., Jan 28 2020, In : The Journal of clinical psychiatry. 81, 2

Research output: Contribution to journalArticle

Delphi Technique
Consensus
Journal Impact Factor
Publications
Antipsychotic Agents

The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures

Kraus, M. S., Gold, J. M., Barch, D. M., Walker, T. M., Chun, C. A., Buchanan, R. W., Csernansky, J. G., Goff, D. C., Green, M. F., Jarskog, L. F., Javitt, D. C., Kimhy, D., Lieberman, J. A., McEvoy, J. P., Mesholam-Gately, R. I., Seidman, L. J., Ball, M. P., Kern, R. S., McMahon, R. P., Robinson, J. & 2 others, Marder, S. R. & Keefe, R. S. E., Mar 2020, In : Schizophrenia Research: Cognition. 19, 100161.

Research output: Contribution to journalArticle

Open Access
Psychometrics
Cognition
Schizophrenia
Clinical Trials
Neuropsychological Tests
2019

34 Long-Term Deutetrabenazine Treatment Response in Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonists and Baseline Comorbidities

Anderson, K. E., Stamler, D., Davis, M. D., Hauser, R. A., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., Ochudlo, S., McEvoy, J. P. & Fernandez, H. H., Feb 1 2019, In : CNS spectrums. 24, 1, 1 p.

Research output: Contribution to journalArticle

Open Access
Dopamine Antagonists
Comorbidity
Psychotic Disorders
Psychiatry
Mood Disorders

35 Long-term Improvements in Site-Rated Outcomes with Deutetrabenazine Treatment in Patients with Tardive Dyskinesia

Anderson, K. E., Stamler, D., Davis, M. D., Gross, N., Hauser, R. A., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., Ochudlo, S., McEvoy, J. P. & Fernandez, H. H., Feb 1 2019, In : CNS spectrums. 24, 1, p. 193-194 2 p.

Research output: Contribution to journalArticle

Open Access
Placebos
Therapeutics
Dyskinesias
deutetrabenazine
Tardive Dyskinesia

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: The past, present, and future

Citrome, L., McEvoy, J. P., Todtenkopf, M. S., McDonnell, D. & Weiden, P. J., Jan 1 2019, In : Neuropsychiatric Disease and Treatment. 15, p. 2559-2569 11 p.

Research output: Contribution to journalReview article

Open Access
olanzapine
Antipsychotic Agents
Schizophrenia
Therapeutics
Weight Gain
2 Citations (Scopus)

Characterizing treatment effects of valbenazine for tardive dyskinesia: Additional results from the KINECT 3 study

Correll, C. U., Cutler, A. J., Kane, J. M., McEvoy, J. P., Liang, G. S. & O'Brien, C. F., Jan 2019, In : Journal of Clinical Psychiatry. 80, 1

Research output: Contribution to journalArticle

Placebos
Body Regions
Diagnostic and Statistical Manual of Mental Disorders
Therapeutics
Odds Ratio

Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia

McEvoy, J., Gandhi, S. K., Rizio, A. A., Maher, S., Kosinski, M., Bjorner, J. B. & Carroll, B., Dec 1 2019, In : Quality of Life Research. 28, 12, p. 3303-3312 10 p.

Research output: Contribution to journalArticle

Open Access
Major Depressive Disorder
Bipolar Disorder
Schizophrenia
Quality of Life
Movement Disorders

FDA-Approved Medications to Treat Tardive Dyskinesia

McEvoy, J. P., Dec 17 2019, In : The Journal of clinical psychiatry. 81, 1

Research output: Contribution to journalArticle

Medication Adherence
Dyskinesias
Dopamine Receptors
Therapeutics
Antipsychotic Agents
1 Citation (Scopus)

Heterogeneity of treatment effects of long-acting injectable antipsychotic medications

Stroup, T. S., Bareis, N. A., Rosenheck, R. A., Swartz, M. S. & McEvoy, J. P., Jan 2019, In : Journal of Clinical Psychiatry. 80, 1

Research output: Contribution to journalArticle

Antipsychotic Agents
Injections
Substance-Related Disorders
Therapeutics
Schizophrenia
Mood Disorders
Schizophrenia
Antipsychotic Agents
Dopamine Receptors
Bipolar Disorder

The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders

McEvoy, J. P., Park, T., Schilling, T., Terasawa, E., Ayyagari, R. & Carroll, B., Jul 3 2019, In : Current Medical Research and Opinion. 35, 7, p. 1205-1214 10 p.

Research output: Contribution to journalArticle

Mental Disorders
Antipsychotic Agents
Inpatients
Delivery of Health Care
Tardive Dyskinesia
Clinical Trials, Phase I
Adipokines
Leukocyte Count
Antipsychotic Agents
Schizophrenia
2018
2 Citations (Scopus)

Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women with Psychosis: Results from the DAAMSEL Clinical Trial

Kelly, D. L., Powell, M. M., Wehring, H. J., Sayer, M. A., Kearns, A. M., Hackman, A. L., Buchanan, R. W., Nichols, R. B., Adams, H. A., Richardson, C. M., Vyas, G., McMahon, R. P., Earl, A. K., Sullivan, K. M., Liu, F., Luttrell, S. E., Dickerson, F. B., Feldman, S. M., Narang, S., Koola, M. M. & 3 others, Buckley, P. F., Rachbeisel, J. A. & McEvoy, J. P., Aug 1 2018, In : Journal of Clinical Psychopharmacology. 38, 4, p. 317-326 10 p.

Research output: Contribution to journalArticle

Prolactin
Psychotic Disorders
Clinical Trials
Placebos
Galactorrhea
5 Citations (Scopus)

Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels

Wehring, H. J., Elsobky, T., McEvoy, J. P., Vyas, G., Richardson, C. M., McMahon, R. P., DiPaula, B. A., Liu, F., Sullivan, K., Buchanan, R. W., Feldman, S., McMahon, E. M. & Kelly, D. L., Mar 1 2018, In : Psychiatric Quarterly. 89, 1, p. 73-80 8 p.

Research output: Contribution to journalArticle

Minocycline
Clozapine
Schizophrenia
Cytochrome P-450 CYP1A2
norclozapine

Evidence-Based Strategies for Managing Tardive Dyskinesia

McEvoy, J. P., Jan 1 2018, In : The Journal of clinical psychiatry. 79, 1

Research output: Contribution to journalArticle

Bipolar Disorder
Tardive Dyskinesia
8 Citations (Scopus)
Clinical Trials, Phase I
Cannabis
Psychopathology
Cocaine
Cognition
5 Citations (Scopus)

Revisiting the abnormal involuntary movement scale: Proceedings from the tardive dyskinesia assessment workshop

Kane, J. M., Correll, C. U., Nierenberg, A. A., Caroff, S. N., Sajatovic, M., Cutler, A. J., McEvoy, J. P. & Stacy, M., May 1 2018, In : Journal of Clinical Psychiatry. 79, 3, 17cs11959.

Research output: Contribution to journalArticle

Education
Clinical Trials
Telecommunications
Tardive Dyskinesia
Abnormal Involuntary Movement Scale
1 Citation (Scopus)

What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options

Manning, J. S. & McEvoy, J. P., Jan 1 2018, In : The Journal of clinical psychiatry. 79, 1

Research output: Contribution to journalArticle

Webcasts
Therapeutics
Tardive Dyskinesia
2017
63 Citations (Scopus)

Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial

Anderson, K. E., Stamler, D., Davis, M. D., Factor, S. A., Hauser, R. A., Isojärvi, J., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., McEvoy, J. P., Ochudlo, S., Ondo, W. G. & Fernandez, H. H., Aug 2017, In : The Lancet Psychiatry. 4, 8, p. 595-604 10 p.

Research output: Contribution to journalArticle

Dyskinesias
Placebos
Therapeutics
Dopamine Antagonists
Patient Safety
5 Citations (Scopus)

Durability of therapeutic response with long-term aripiprazole lauroxil treatment following successful resolution of an acute episode of Schizophrenia

McEvoy, J. P., Risinger, R., Mykhnyak, S., Du, Y., Liu, C. C., Stanford, A. D. & Weiden, P. J., Sep 1 2017, In : Journal of Clinical Psychiatry. 78, 8, p. 1103-1109 7 p.

Research output: Contribution to journalArticle

Schizophrenia
Therapeutic Uses
Therapeutics
aripiprazole lauroxil
Randomized Controlled Trials
2 Citations (Scopus)

Prioritizing Harm

Moyer, K. H., McEvoy, J. P., Mabe, P. A., Buchanan, E., Venkatesan, A. & Buckley, P. F., Jan 2 2017, In : Journal of Personality Assessment. 99, 1, p. 78-82 5 p.

Research output: Contribution to journalArticle

Personality
Psychotic Disorders
State Hospitals
Self Report
Inpatients

What's new in our understanding of schizophrenia

McEvoy, J. P., Feb 2017, In : Psychiatric Times. 34, 2

Research output: Contribution to journalArticle

Schizophrenia
2016
24 Citations (Scopus)

A guide to the management of clozapine-related tolerability and safety concerns

Citrome, L., McEvoy, J. P. & Saklad, S. R., Sep 1 2016, In : Clinical Schizophrenia and Related Psychoses. 10, 3, p. 163-177D

Research output: Contribution to journalReview article

Clozapine
Safety
Agranulocytosis
Sialorrhea
Enuresis
12 Citations (Scopus)

Brexpiprazole for the treatment of schizophrenia: A review of this novel serotonin-dopamine activity modulator

McEvoy, J. P. & Citrome, L., Dec 1 2016, In : Clinical Schizophrenia and Related Psychoses. 9, 4, p. 177-186 10 p.

Research output: Contribution to journalReview article

Dopamine
Serotonin
Schizophrenia
Placebos
Therapeutics
8 Citations (Scopus)

Cost-effectiveness of long-acting injectable paliperidone palmitate versus haloperidol decanoate in maintenance treatment of schizophrenia

Rosenheck, R. A., Leslie, D. L., Sint, K. J., Lin, H., Li, Y., McEvoy, J. P., Byerly, M. J., Hamer, R. M., Swartz, M. S. & Stroup, T. S., Oct 1 2016, In : Psychiatric Services. 67, 10, p. 1124-1130 7 p.

Research output: Contribution to journalArticle

Cost-Benefit Analysis
Quality-Adjusted Life Years
Schizophrenia
Injections
Antipsychotic Agents
2 Citations (Scopus)

Placebo controls in clinical trials: concerns about use in relapse prevention studies in schizophrenia

Emsley, R., Fleischhacker, W. W., Galderisi, S., Halpern, L. J., McEvoy, J. P. & Schooler, N. R., Sep 9 2016, In : BMJ (Clinical research ed.). 354, p. i4728

Research output: Contribution to journalArticle

Drug and Narcotic Control
Secondary Prevention
Antipsychotic Agents
Schizophrenia
Placebos
6 Citations (Scopus)

The RAISE connection program: Psychopharmacological treatment of people with a first episode of schizophrenia

Kreyenbuhl, J. A., Medoff, D. R., McEvoy, J. P., Smith, T. E., Hackman, A. L., Nossel, I. R., Dixon, L. B., Essock, S. M. & Buchanan, R. W., Dec 1 2016, In : Psychiatric Services. 67, 12, p. 1300-1306 7 p.

Research output: Contribution to journalArticle

Antipsychotic Agents
Schizophrenia
Appointments and Schedules
Psychiatry
olanzapine
2 Citations (Scopus)

To the Editor

McEvoy, J. P., Oct 1 2016, In : JAMA Psychiatry. 73, 10, p. 1097-1098 2 p.

Research output: Contribution to journalLetter